How Much Does Testosterone Enanthate Cost in Nebraska in 2026?

Nebraska Retail Pricing Breakdown

The average cash-pay price for testosterone enanthate across Nebraska retail pharmacies is $70 per month in 2026. That figure reflects a standard 200 mg/mL vial dispensed for weekly intramuscular injection at doses between 100 and 200 mg.

Manufacturer list price for branded testosterone enanthate products sits at $120 per month, but few patients pay that amount out of pocket. Retail chains in Omaha, Lincoln, and smaller Nebraska markets compete on generic pricing, which pushes actual shelf cost well below list. A 5 mL vial of generic testosterone enanthate (1 to 000 mg total) typically costs between $40 and $90 depending on the pharmacy, and that single vial covers 5 to 10 weeks of therapy at standard doses.

Pricing varies by pharmacy location and purchasing volume. Larger pharmacies in metropolitan Omaha tend to offer lower per-unit costs than rural dispensaries, though mail-order options narrow that gap. The Endocrine Society's 2018 clinical practice guideline recommends testosterone enanthate as a first-line injectable option for testosterone replacement therapy (TRT), making it one of the most commonly dispensed formulations nationwide and keeping generic competition strong.

Patients filling a 10 mL vial (2 to 000 mg) can reduce per-dose cost further. At a typical 150 mg weekly dose, a 10 mL vial lasts roughly 13 weeks and costs between $60 and $130 cash, bringing the monthly cost as low as $20 to $40 at the most competitive pharmacies.

Nebraska Medicaid Coverage

Nebraska Medicaid does not cover testosterone enanthate for the treatment of male hypogonadism. This exclusion applies to both branded and generic formulations.

Patients enrolled in Heritage Health managed care plans (the three MCOs administering Nebraska Medicaid) face the same exclusion. The Nebraska Department of Health and Human Services formulary classifies testosterone replacement as a non-covered benefit for adult males, consistent with several other state Medicaid programs that exclude TRT unless specific narrow criteria are met. Female-to-male gender-affirming hormone therapy may follow different coverage pathways under Nebraska Medicaid's behavioral health carve-out, but that falls outside the scope of standard hypogonadism treatment.

For Medicaid-enrolled patients who have a clinical diagnosis of hypogonadism confirmed by two morning serum testosterone levels below 300 ng/dL, as recommended by the American Urological Association, alternative payment routes include pharmacy discount programs, 503A compounding pharmacies, and patient assistance programs. The T-Trials, a coordinated set of seven placebo-controlled trials published in the New England Journal of Medicine (N=790 men aged 65 and older), demonstrated that testosterone gel improved sexual function, physical activity, and mood in hypogonadal older men 1. These findings reinforced the clinical rationale for TRT coverage, though policy adoption by state Medicaid programs remains inconsistent.

Private Insurance Coverage in Nebraska

Most major private insurers operating in Nebraska, including Blue Cross Blue Shield of Nebraska, UnitedHealthcare, Aetna, and Medica, cover generic testosterone enanthate with prior authorization.

Prior authorization requirements typically mandate two confirmed early-morning serum total testosterone levels below 300 ng/dL drawn on separate days, documented signs or symptoms of hypogonadism, and exclusion of reversible causes such as opioid use, obesity, or pituitary pathology. The Endocrine Society guideline specifies measuring testosterone between 8:00 and 10:00 AM, when circulating levels peak, and repeating the measurement to confirm persistent deficiency before initiating therapy.

"Testosterone therapy should be offered to men with symptomatic testosterone deficiency to induce and maintain secondary sex characteristics and to improve sexual function, sense of well-being, and bone mineral density," the Endocrine Society guideline states.

Copay amounts vary by plan tier. Patients on high-deductible health plans may pay full cash price until their deductible is met, making discount cards valuable even for insured individuals during the deductible phase. Plans sold through the Nebraska ACA marketplace (Healthcare.gov) generally include injectable testosterone on their formularies as a Tier 1 or Tier 2 generic, with copays ranging from $5 to $30 per fill after prior authorization approval.

Employer-sponsored plans dominate private coverage in Nebraska, and formulary placement depends on the pharmacy benefit manager (PBM) each employer contracts. Express Scripts, CVS Caremark, and OptumRx all list generic testosterone enanthate on their national formularies, though step therapy requirements occasionally mandate a trial of topical testosterone gel before approving injectables.

Compounded Testosterone Enanthate in Nebraska

Compounded testosterone enanthate is legal in Nebraska through licensed 503A compounding pharmacies. The average cost is approximately $80 per month.

Section 503A of the Federal Food, Drug, and Cosmetic Act permits state-licensed pharmacies to compound medications based on individual patient prescriptions. Nebraska's pharmacy practice act, administered by the Nebraska Board of Pharmacy, allows 503A compounding provided the pharmacy holds a valid Nebraska license and compounds in response to a valid prescription for an identified individual patient. The FDA's compounding guidance outlines federal requirements that complement state oversight.

Compounded testosterone enanthate may cost more than generic commercial product at some pharmacies, which seems counterintuitive. The price difference reflects several factors: compounding pharmacies often use pharmaceutical-grade raw materials from FDA-registered suppliers, compound in smaller batches with manual quality checks, and bundle the cost of beyond-use date testing into the per-vial price. Some patients prefer compounded formulations because pharmacies can customize concentration (e.g., 250 mg/mL or 300 mg/mL instead of the standard 200 mg/mL), adjust carrier oils to reduce injection-site irritation, or combine testosterone with other prescribed compounds.

503B outsourcing facilities, which compound without individual prescriptions under current Good Manufacturing Practice (cGMP) standards, represent a separate regulatory category. These facilities can ship to Nebraska providers, but pricing and availability depend on the specific outsourcing facility. The FDA maintains a registry of registered 503B facilities that Nebraska clinicians can reference.

Telehealth TRT Prescribing in Nebraska

Nebraska permits telehealth prescribing of testosterone enanthate. A valid prescriber-patient relationship can be established via audio-video telemedicine under Nebraska Revised Statute 71-8503.

This means Nebraska residents can receive a testosterone enanthate prescription from a licensed prescriber during a synchronous video visit without a prior in-person examination. The prescriber must hold an active Nebraska medical license or practice under a multi-state compact that covers Nebraska. Audio-only telephone visits do not satisfy the requirement for controlled substance prescribing in most circumstances.

Telehealth has expanded TRT access for patients in rural Nebraska counties where endocrinology or urology specialists may be hours away. According to HRSA data, 61 of Nebraska's 93 counties are designated as Health Professional Shortage Areas for primary care, making remote prescribing particularly relevant for hormone therapy access.

After the prescriber issues an electronic prescription (EPCS for Schedule III), the patient can fill it at any Nebraska-licensed pharmacy, including mail-order pharmacies licensed to dispense in the state. Mail-order fills often deliver 90-day supplies, which can reduce per-month cost and minimize pharmacy trips.

How to Find the Lowest Price in Nebraska

Several strategies can reduce testosterone enanthate cost below the $70 average.

Request the larger vial. A 10 mL vial costs modestly more than a 5 mL vial but delivers twice the medication. If your prescribed dose is 150 mg per week, a 10 mL (2 to 000 mg) vial lasts about 13 weeks. Many pharmacies charge $80 to $130 for the larger vial, yielding a monthly cost of $25 to $40.

Use a pharmacy discount card. GoodRx, RxSaver, and similar platforms aggregate discount pricing from PBM networks. These cards are accepted at most Nebraska chain pharmacies and can reduce cash price by 20 to 60 percent below the pharmacy's standard retail. Discount cards are not insurance and cannot be combined with insurance copays, but they sometimes beat the insured copay, especially during deductible periods.

Compare independent pharmacies. Independent pharmacies in Nebraska sometimes price testosterone enanthate lower than chains because they purchase through different wholesalers. Call two or three pharmacies before filling.

Consider mail-order. Licensed mail-order pharmacies that ship to Nebraska can offer competitive pricing, particularly on 90-day fills. Verify the pharmacy holds a valid Nebraska non-resident pharmacy license through the Nebraska Board of Pharmacy.

Ask about manufacturer savings cards. Some branded testosterone enanthate products offer copay assistance cards that reduce out-of-pocket cost to $0 to $30 per fill for commercially insured patients. These cards typically exclude government insurance (Medicaid, Medicare, Tricare).

A 2020 analysis in JAMA Internal Medicine found that testosterone product prices varied by more than 10-fold across U.S. pharmacies for the same formulation, underscoring the value of price comparison before every fill 2.

Clinical Monitoring and Ongoing Costs

The cost of testosterone enanthate itself represents only part of the total expense. Ongoing monitoring labs add $50 to $300 per panel depending on insurance status.

The Endocrine Society recommends checking serum testosterone levels 3 to 6 months after initiating therapy, then annually. Each monitoring visit should also include a complete blood count (CBC) to screen for erythrocytosis, a known dose-dependent effect of exogenous testosterone. Hematocrit levels exceeding 54% require dose reduction or temporary discontinuation, per guideline recommendations.

"We recommend against testosterone therapy in men who are planning fertility in the near term," the Endocrine Society guideline notes, because exogenous testosterone suppresses gonadotropins and spermatogenesis 3.

Additional labs drawn at baseline and periodically include PSA (prostate-specific antigen), lipid panel, and hepatic function. The T-Trials cardiovascular substudy found that testosterone treatment was associated with increased coronary artery plaque volume measured by CT angiography, a finding that prompted the FDA to require a cardiovascular risk warning on all testosterone product labels in 2015 4.

The TRAVERSE trial (N=5,246 men with hypogonadism and cardiovascular risk factors), published in 2023, provided more reassuring data: testosterone replacement did not increase the incidence of major adverse cardiovascular events compared with placebo over a median follow-up of 33 months 5. This trial led to updated clinical thinking about cardiovascular safety, though the FDA label warning remains in effect.

Patients should budget for quarterly to semiannual lab draws in the first year and annual labs thereafter, in addition to the medication cost itself.

Supplies and Administration Costs

Testosterone enanthate is administered by intramuscular injection. Patients who self-inject at home need syringes, drawing needles, and injection needles.

A box of 100 syringes with needles costs $15 to $30 from medical supply retailers and lasts nearly two years at a once-weekly injection schedule. Drawing needles (18-gauge) and injection needles (22- to 25-gauge, 1 to 1.5 inch) are sold separately or in kits. Total annual supply cost for self-injection runs $20 to $50.

Patients who prefer in-office injections will pay a nursing visit fee, typically $20 to $40 per injection at primary care clinics. At weekly dosing, in-office administration adds $80 to $160 per month, which substantially increases total therapy cost. The subcutaneous injection route, using a shorter 27- to 30-gauge needle, has gained acceptance based on pharmacokinetic data showing comparable testosterone absorption 6, and many patients find it easier to self-administer.

Nebraska-Specific Savings Programs

No Nebraska state-funded program specifically subsidizes testosterone enanthate. Patients seeking cost assistance have these options.

Federally Qualified Health Centers (FQHCs) in Nebraska, including OneWorld Community Health Centers in Omaha and People's Health Center in Lincoln, participate in the 340B Drug Pricing Program. Eligible patients receiving care at 340B-covered entities may access testosterone enanthate at significantly reduced prices, sometimes 25 to 50 percent below standard wholesale.

Patient assistance programs from generic manufacturers are limited, but GoodRx Gold and similar subscription discount services ($5.99 to $9.99 per month) can lock in preferred pricing at participating Nebraska pharmacies, often reducing testosterone enanthate cost to $30 to $50 for a 5 mL vial.

Veterans enrolled at the VA Nebraska-Western Iowa Health Care System in Omaha receive testosterone enanthate through the VA pharmacy at no copay or minimal copay ($5 for a 30-day supply), provided clinical criteria are met.

For commercially insured patients whose plans require high copays, manufacturer copay cards for branded testosterone enanthate (such as Delatestryl) may reduce per-fill cost to a fixed amount, though generic substitution makes branded products uncommon.